血清能功能障碍会损害脊柱肌肉缩中的运动协调
Nicolas Delestrée1,2, Evangelia Semizoglou1,2, John G Pagiazitis1,2
1Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Brain : a journal of neurology
|September 7, 2023
概括
脊髓肌肉缩 (SMA) 导致运动神经元中严重的血清素 (5-HT) 神经传递功能障碍,导致运动障碍. 在5-HT神经元中恢复SMN蛋白质可以改善SMA小鼠的运动控制.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 运动神经元疾病 运动神经元疾病
背景情况:
- 血清素 (5-HT) 对于调节神经网络和运动行为至关重要.
- serotonergic神经递质的失调与情绪障碍和脊髓损伤有关,但其在运动障碍中的作用尚不清楚.
- 脊髓肌肉缩 (SMA) 是一种神经退行性疾病,其特点是由于SMN蛋白缺乏而导致运动神经元损失和肌肉缩.
研究的目的:
- 在脊髓肌肉缩 (SMA) 的小鼠模型中研究血清神经调节.
- 为了确定SMN缺乏是否会影响脊髓和脑干中的血清激素信号传递.
- 探索针对SMA中血清路的治疗潜力.
主要方法:
- 利用一种严重的SMA小鼠模型重复I型SMA症状.
- 雇佣了老鼠遗传学,光遗传学,生理学,形态学和行为分析.
- 评估了血清激素神经递质,5-HT突触密度和运动神经元功能.
主要成果:
- 在SMA小鼠中,在疾病早期和晚期都发现了血清激素神经传递的严重功能障碍.
- 观察到运动神经元上的5-HT突触减少,特别是那些内化轴和干肌的运动神经元.
- 证明大脑干中神经元中的SMN缺乏导致这种功能障碍,导致肢体间失调.
结论:
- SMA涉及显著的血清激素神经调节缺陷,可能有助于疾病进展和脊柱病.
- 在血清神经元中选择性恢复SMN可改善SMA小鼠的运动失调.
- 准5-HT神经调节是一种有前途的SMA治疗策略.
相关概念视频
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
297
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
297
01:24Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
01:15Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592